• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于肝脏硬度值的肝细胞癌根治性切除术后晚期复发风险评估:预测模型的建立与验证

Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.

作者信息

Jung Kyu Sik, Kim Ji Hong, Kim Seung Up, Song Kijun, Kim Beom Kyung, Park Jun Yong, Kim Do Young, Ahn Sang Hoon, Moon Do Chang, Song In Ji, Choi Gi Hong, Park Young Nyun, Han Kwang-Hyub

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea; Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea; Liver Cancer Special Clinic, Yonsei University College of Medicine, Seoul, Korea; Liver Cirrhosis Clinical Research Center, Seoul, Korea.

出版信息

PLoS One. 2014 Jun 9;9(6):e99167. doi: 10.1371/journal.pone.0099167. eCollection 2014.

DOI:10.1371/journal.pone.0099167
PMID:24910997
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4049628/
Abstract

BACKGROUND

Preoperative liver stiffness (LS) measurement using transient elastography (TE) is useful for predicting late recurrence after curative resection of hepatocellular carcinoma (HCC). We developed and validated a novel LS value-based predictive model for late recurrence of HCC.

METHODS

Patients who were due to undergo curative resection of HCC between August 2006 and January 2010 were prospectively enrolled and TE was performed prior to operations by study protocol. The predictive model of late recurrence was constructed based on a multiple logistic regression model. Discrimination and calibration were used to validate the model.

RESULTS

Among a total of 139 patients who were finally analyzed, late recurrence occurred in 44 patients, with a median follow-up of 24.5 months (range, 12.4-68.1). We developed a predictive model for late recurrence of HCC using LS value, activity grade II-III, presence of multiple tumors, and indocyanine green retention rate at 15 min (ICG R15), which showed fairly good discrimination capability with an area under the receiver operating characteristic curve (AUROC) of 0.724 (95% confidence intervals [CIs], 0.632-0.816). In the validation, using a bootstrap method to assess discrimination, the AUROC remained largely unchanged between iterations, with an average AUROC of 0.722 (95% CIs, 0.718-0.724). When we plotted a calibration chart for predicted and observed risk of late recurrence, the predicted risk of late recurrence correlated well with observed risk, with a correlation coefficient of 0.873 (P<0.001).

CONCLUSION

A simple LS value-based predictive model could estimate the risk of late recurrence in patients who underwent curative resection of HCC.

摘要

背景

使用瞬时弹性成像(TE)术前测量肝脏硬度(LS)有助于预测肝细胞癌(HCC)根治性切除术后的晚期复发。我们开发并验证了一种基于新型LS值的HCC晚期复发预测模型。

方法

前瞻性纳入2006年8月至2010年1月期间计划接受HCC根治性切除的患者,并按照研究方案在术前进行TE检查。基于多因素逻辑回归模型构建晚期复发预测模型。采用辨别力和校准来验证该模型。

结果

最终分析的139例患者中,44例出现晚期复发,中位随访时间为24.5个月(范围12.4 - 68.1个月)。我们使用LS值、活动度II - III级、多肿瘤存在情况以及15分钟时的吲哚菁绿滞留率(ICG R15)建立了HCC晚期复发预测模型,该模型显示出相当好的辨别能力,受试者工作特征曲线下面积(AUROC)为0.724(95%置信区间[CI],0.632 - 0.816)。在验证中,使用自助法评估辨别力,各次迭代间AUROC基本保持不变,平均AUROC为0.722(95% CI,0.718 - 0.724)。当绘制预测和观察到的晚期复发风险校准图时,预测的晚期复发风险与观察到的风险相关性良好,相关系数为0.873(P<0.001)。

结论

一个简单的基于LS值的预测模型可以估计接受HCC根治性切除患者的晚期复发风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/ca12613a9fdd/pone.0099167.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/d4dfabdc2537/pone.0099167.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/cd0d2398f7ec/pone.0099167.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/ca12613a9fdd/pone.0099167.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/d4dfabdc2537/pone.0099167.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/cd0d2398f7ec/pone.0099167.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d85d/4049628/ca12613a9fdd/pone.0099167.g003.jpg

相似文献

1
Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma: development and validation of a predictive model.基于肝脏硬度值的肝细胞癌根治性切除术后晚期复发风险评估:预测模型的建立与验证
PLoS One. 2014 Jun 9;9(6):e99167. doi: 10.1371/journal.pone.0099167. eCollection 2014.
2
Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection.肝脏和脾脏硬度在预测肝癌切除术后复发中的作用。
J Hepatol. 2019 Mar;70(3):440-448. doi: 10.1016/j.jhep.2018.10.022. Epub 2018 Oct 31.
3
Magnetic resonance elastography-based prediction of hepatocellular carcinoma recurrence after curative resection.基于磁共振弹性成像的肝细胞癌根治性切除术后复发预测。
Surgery. 2021 Jul;170(1):167-172. doi: 10.1016/j.surg.2021.02.027. Epub 2021 Mar 19.
4
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.用于预测肝细胞癌根治性切除术后早期复发的术前血清肝酶标志物。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):178-85. doi: 10.1016/s1499-3872(15)60353-8.
5
Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®).使用肝脏硬度测量(FibroScan®)预测肝癌根治性切除术后复发。
Ann Surg Oncol. 2012 Dec;19(13):4278-86. doi: 10.1245/s10434-012-2422-3. Epub 2012 Jul 3.
6
Using transient elastography to predict hepatocellular carcinoma recurrence after radiofrequency ablation.使用瞬时弹性成像预测射频消融术后肝细胞癌复发
J Gastroenterol Hepatol. 2017 May;32(5):1079-1086. doi: 10.1111/jgh.13644.
7
Feasibility of liver stiffness measured using two-dimensional shear wave elastography in assessing preoperative liver function for patients with hepatocellular carcinoma.二维剪切波弹性成像测量肝硬度评估肝细胞癌患者术前肝功能的可行性。
Abdom Radiol (NY). 2022 Feb;47(2):664-671. doi: 10.1007/s00261-021-03374-4. Epub 2021 Dec 16.
8
Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection.肝硬度和胰岛素抵抗预测早期肝癌患者根治性切除术后复发的价值。
Sci Rep. 2021 Mar 15;11(1):6041. doi: 10.1038/s41598-021-85431-y.
9
Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.利用CLIP评分预测肝细胞癌患者切除术后的复发及预后
World J Gastroenterol. 2002 Apr;8(2):237-42. doi: 10.3748/wjg.v8.i2.237.
10
Liver stiffness measured by acoustic radiation force impulse elastography predicted prognoses of hepatocellular carcinoma after radiofrequency ablation.声辐射力脉冲弹性成像技术测量的肝脏硬度可预测肝癌经射频消融治疗后的预后。
Sci Rep. 2020 Feb 6;10(1):2006. doi: 10.1038/s41598-020-58988-3.

引用本文的文献

1
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.KASL慢性肝病肝纤维化评估无创检测临床实践指南。
Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.
2
Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.肝移植前门静脉减压是否会影响肝癌复发?一项巢式病例对照研究。
BMC Cancer. 2024 May 3;24(1):558. doi: 10.1186/s12885-024-12322-6.
3
Prediction of late recurrence after curative-intent resection using MRI-measured spleen volume in patients with hepatocellular carcinoma and cirrhosis.

本文引用的文献

1
A mathematical model to predict short-term recurrence and metastasis of primary hepatocellular carcinoma larger than 10 cm in diameter.
Hepatogastroenterology. 2013 Mar-Apr;60(122):225-30. doi: 10.5754/hge.
2
Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes.瞬时弹性成像测量肝硬度作为预测肝切除术后结局的指标。
Ann Surg. 2013 May;257(5):922-8. doi: 10.1097/SLA.0b013e318269d2ec.
3
Clinical applications of transient elastography.瞬时弹性成像技术的临床应用。
利用磁共振成像测量的脾脏体积预测肝细胞癌合并肝硬化患者根治性切除术后的晚期复发
Insights Imaging. 2024 Feb 2;15(1):31. doi: 10.1186/s13244-024-01609-8.
4
Stiffness on shear wave elastography as a potential microenvironment biomarker for predicting tumor recurrence in HBV-related hepatocellular carcinoma.剪切波弹性成像中的硬度作为预测乙肝相关肝细胞癌肿瘤复发的潜在微环境生物标志物。
Insights Imaging. 2023 Sep 12;14(1):147. doi: 10.1186/s13244-023-01505-7.
5
Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy.停止肝炎活动可降低原发性根治性治疗后肝细胞癌的复发率。
J Pers Med. 2023 Feb 24;13(3):397. doi: 10.3390/jpm13030397.
6
Hypervascular Nodules and Stiffer Liver are Associated with Recurrence after Microwave Ablation in Patients with Hepatocellular Carcinoma: A Double-Center Analysis.肝细胞癌患者微波消融术后高血管结节和肝脏硬度增加与复发相关:一项双中心分析
South Asian J Cancer. 2020 Jul;9(3):153-157. doi: 10.1055/s-0041-1723102. Epub 2021 Mar 19.
7
Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database.Child-Pugh A级肝硬化患者单发大肝细胞癌肝切除的疗效:基于全国癌症登记数据库的分析
Front Oncol. 2021 Apr 30;11:674603. doi: 10.3389/fonc.2021.674603. eCollection 2021.
8
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests?门静脉高压症的诊断方法:非侵入性检查还是侵入性检查?
Hepat Med. 2021 Mar 18;13:25-36. doi: 10.2147/HMER.S278077. eCollection 2021.
9
Liver stiffness and insulin resistance in predicting recurrence for early stage hepatoma patients after curative resection.肝硬度和胰岛素抵抗预测早期肝癌患者根治性切除术后复发的价值。
Sci Rep. 2021 Mar 15;11(1):6041. doi: 10.1038/s41598-021-85431-y.
10
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study.新的经导管动脉化疗栓塞术治疗术后复发肝癌风险评分的建立:一项多中心研究。
Gut Liver. 2020 Jul 15;14(4):477-485. doi: 10.5009/gnl19111.
Clin Mol Hepatol. 2012 Jun;18(2):163-73. doi: 10.3350/cmh.2012.18.2.163. Epub 2012 Jun 26.
4
Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®).使用肝脏硬度测量(FibroScan®)预测肝癌根治性切除术后复发。
Ann Surg Oncol. 2012 Dec;19(13):4278-86. doi: 10.1245/s10434-012-2422-3. Epub 2012 Jul 3.
5
Hepatitis B virus surface antigen-negative and hepatitis C virus antibody-negative hepatocellular carcinoma: clinical characteristics, outcome, and risk factors for early and late intrahepatic recurrence after resection.乙型肝炎病毒表面抗原阴性和丙型肝炎病毒抗体阴性肝细胞癌:切除术后早期和晚期肝内复发的临床特征、结局和危险因素。
Cancer. 2013 Jan 1;119(1):126-35. doi: 10.1002/cncr.27697. Epub 2012 Jun 26.
6
The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.非侵入性方法在预测慢性乙型肝炎患者肝细胞癌和肝功能失代偿发展中的准确性。
J Clin Gastroenterol. 2012 Jul;46(6):518-25. doi: 10.1097/MCG.0b013e31825079f1.
7
Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.应用 Fibroscan 预测慢性乙型肝炎患者发生肝相关事件的研究。
PLoS One. 2012;7(5):e36676. doi: 10.1371/journal.pone.0036676. Epub 2012 May 4.
8
Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation.肝活检与 Fibroscan® 在评估慢性乙型肝炎肝纤维化中的差异:危险因素和坏死炎症的影响。
PLoS One. 2012;7(2):e32233. doi: 10.1371/journal.pone.0032233. Epub 2012 Feb 23.
9
Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.慢性病毒性肝炎患者血清标志物与氨基转移酶水平正常或轻度升高的坏死性炎症活动。
Liver Int. 2011 Oct;31(9):1352-8. doi: 10.1111/j.1478-3231.2011.02570.x. Epub 2011 Jun 23.
10
Management of hepatocellular carcinoma: an update.肝细胞癌的管理:最新进展
Hepatology. 2011 Mar;53(3):1020-2. doi: 10.1002/hep.24199.